433 related articles for article (PubMed ID: 29097204)
1. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
[TBL] [Abstract][Full Text] [Related]
3. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
4. Hybrid nanoparticles based on ortho ester-modified pluronic L61 and chitosan for efficient doxorubicin delivery.
Xu X; Xue Y; Fang Q; Qiao Z; Liu S; Wang X; Tang R
Int J Biol Macromol; 2021 Jul; 183():1596-1606. PubMed ID: 34022312
[TBL] [Abstract][Full Text] [Related]
5. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity.
Xie P; Liu P
Carbohydr Polym; 2022 Jan; 275():118760. PubMed ID: 34742449
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
[TBL] [Abstract][Full Text] [Related]
8. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
9. Nanogels fabricated from bovine serum albumin and chitosan via self-assembly for delivery of anticancer drug.
Wang Y; Xu S; Xiong W; Pei Y; Li B; Chen Y
Colloids Surf B Biointerfaces; 2016 Oct; 146():107-13. PubMed ID: 27262260
[TBL] [Abstract][Full Text] [Related]
10. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
Siddharth S; Nayak A; Nayak D; Bindhani BK; Kundu CN
Sci Rep; 2017 May; 7(1):2143. PubMed ID: 28526868
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
14. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
15. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
Wang X; Wang L; Tan X; Zhang H; Sun G
J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
Erdem M; Yalcin S; Gunduz U
Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
